Aptorum Group Limited (NASDAQ:APM) and Intec Pharma Ltd. (NASDAQ:NTEC), are influenced by contrast since they are both players in the Biotechnology. These factors are particularly influence the risk, institutional ownership, analyst recommendations, profitability, dividends, earnings and valuation of the two firms.
Demonstrates Aptorum Group Limited and Intec Pharma Ltd. earnings per share (EPS), gross revenue and valuation.
Table 2 demonstrates the return on equity, net margins and return on assets of Aptorum Group Limited and Intec Pharma Ltd.
Insider Institutional Ownership
Roughly 0.02% of Aptorum Group Limited shares are owned by institutional investors while 39.64% of Intec Pharma Ltd. are owned by institutional investors. Insiders owned 29.39% of Aptorum Group Limited shares. Comparatively, Intec Pharma Ltd. has 11.81% of it’s share owned by insiders.
In this table we provide the Weekly, Monthly, Quarterly, Half Yearly,